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Abstract
The purpose of donor evaluation for adult-to-adult living donor liver transplantation (LDLT) is to
discover medical conditions that could increase the donor postoperative risk of complications and
to determine whether the donor can yield a suitable graft for the recipient. We report the outcomes
of LDLT donor candidates evaluated in a large multicenter study of LDLT. The records of all
donor candidates and their respective recipients between 1998 and 2003 were reviewed as part of
the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL). The outcomes of
the evaluation were recorded along with demographic data on the donors and recipients. Of the
1011 donor candidates evaluated, 405 (40%) were accepted for donation. The donor characteristics
associated with acceptance (P < 0.05) were younger age, lower body mass index, and biological or
spousal relationship to the recipient. Recipient characteristics associated with donor acceptance
were younger age, lower Model for End-stage Liver Disease score, and shorter time from listing to
first donor evaluation. Other predictors of donor acceptance included earlier year of evaluation and
transplant center.
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Conclusion—Both donor and recipient features appear to affect acceptance for LDLT. These
findings may aid the donor evaluation process and allow an objective assessment of the likelihood
of donor candidate acceptance.
Donor evaluation is one of the most important aspects of adult-to-adult living donor liver
transplantation (LDLT).1-3 The evaluation process is designed to reveal any condition that
may increase the risk of complications for the donor. In addition, the transplant team should
determine whether the donor will yield a suitable graft for the recipient. The evaluation
process typically proceeds in a stepwise fashion so that unsuitable donors can be identified
as early as possible. Acceptance of donors by the evaluating team implies that they have met
all relevant medical, surgical, psychosocial, and informed consent criteria necessary to
proceed with donor right hepatic lobectomy.
The Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL) is a
multicenter project funded by the National Institutes of Health to evaluate the outcomes of
donors and recipients evaluated for and undergoing this procedure. Although designed with
both retrospective and prospective phases, the data presented in this report are derived from
the retrospective phase of A2ALL. There were three major goals of the analysis: (1) to
describe the characteristics and acceptance rate of donor candidates; (2) to examine the




A2ALL includes nine US liver transplantation centers.4 Between January 1, 1998 and
February 28, 2003, these centers evaluated 819 potential LDLT recipients, for whom 1011
donor candidates were evaluated. Two subsets of these potential donors have been
previously reported in single-center evaluations of this topic.5,6 The donor evaluation is
typically performed in a stepwise fashion beginning with basic laboratory tests, blood type
confirmation, and, at many centers, a basic medical screening questionnaire. Study subject
entry was defined as the date the donor candidate underwent a history and physical
examination as part of the donor evaluation. Thereafter, the donor candidate was either
accepted or not accepted for donation. Data were retrospectively collected on all donor and
LDLT recipient candidates using standardized forms. For 389 of the potential recipients, an
LDLT was performed.
Donor Evaluation Outcomes
The primary reason for not accepting donor candidates was categorized as donor or recipient
related. Donor reasons included: (1) medical contraindication (diagnosis of medical
condition that could increase the risk of short-term or long-term complications in the donor
candidate, such as hypertension, abnormal blood chemistries, or chest radiograph); (2)
anatomic considerations (findings on hepatic cross-sectional imaging that either increase the
risk of hepatectomy in the donor candidate, for example, large hemangioma, or preclude the
donor candidate from yielding a suitable graft, for example, significantly abnormal hepatic
vasculature, or both); (3) donor candidate declined to donate; (4) hepatic histology showing
steatosis greater than 10%; or (5) psychosocial contraindications, such as active substance
abuse. Recipient reasons included: (1) recipients who declined the donor’s offer or (2)
recipients who had a change in condition precluding the feasibility of or need for LDLT
[improvement, deterioration, receipt of a deceased donor liver transplant (DDLT), or death].
To compare candidates wait-listed for liver transplantation who had a potential living donor
with those who did not at the 9 A2ALL centers, we compared potential LDLT recipients
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with the complement of DDLT-listed candidates in the Scientific Registry of Transplant
Recipients (SRTR) database, under a data use agreement. DDLT transplant candidates
included those listed for transplantation between the date of their center’s LDLT program
initiation and February 28, 2003 at each A2ALL center, but who did not have a living donor
evaluated. In addition, SRTR data were used to supplement A2ALL data where available.
The time from a candidate’s listing to the date of his/her first potential donor’s evaluation
was calculated in days and categorized by quartiles. We found no significant difference in
donor acceptance probabilities between the second through fourth quartiles, so this variable
was dichotomized (before day 23 versus day 23 or after) for further analyses. Calendar time
effects on donor acceptance were tested using 1998 to 2000 versus 2001 to 2003.
The Model for End-stage Liver Disease score (MELD) was calculated for the LDLT
candidates at the time of donor evaluation as previously described.7,8 Laboratory-based
MELD was calculated for DDLT candidates listed after September 2001, when MELD
component reporting became a requirement. For statistical comparisons of MELD scores
between LDLT and DDLT candidates, those of LDLT candidates were restricted to the
MELD era.
Body mass index (BMI) of recipient and donor candidates was calculated as weight in
kilograms divided by height in meters squared (kg/m2) at the time of evaluation and
categorized as low (<18.5 kg/m2), normal (18.5-24.9 kg/m2), overweight (25-29.9 kg/m2),
or obese (≥30 kg/m2).9 In the logistic regression analysis, the combined group of
underweight and normal weight served as the reference group.
A history of adverse events or diseases in potential recipients that had the potential to
confound the likelihood of donor acceptance, such as coronary artery disease, diabetes
mellitus, the need for mechanical ventilation, and renal failure, were collected for the
recipient candidates at the time of donor evaluation.
The study was approved by the institutional review boards and privacy boards of the
University of Michigan Data Coordinating Center and each of the 9 participating transplant
centers.
Statistical Analysis
Demographic characteristics of potential donors were tabulated by donor acceptance status.
Demographic and medical characteristics of potential recipients were tabulated by donor
acceptance status and were compared with DDLT candidates not considered for LDLT at the
9 A2ALL centers during the same time period. Donor-related and recipient-related reasons
for donors not being accepted, as well as information on aborted transplant procedures, were
tabulated.
Logistic regression analysis was used to model the probability of donor acceptance as a
function of donor and recipient characteristics. Robust (sandwich estimator) variances were
used to adjust for possible correlation among potential donors of the same recipient. Two-
way interactions were tested and not found to be significant. The strength of overall
covariate prediction was assessed by the c-statistic (based on the area under the receiver
operating characteristic curve), with a value of 0.70 or greater considered to provide
acceptable discrimination.10 Relative covariate predictive ability was assessed by the change
in the c-statistic value (Δc-statistic) when a covariate was removed from the model. All
analyses were performed using SAS version 9.1.
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Role of the Funding Sources
The National Institutes of Health project scientist participated in study design and analysis
and interpretation of data. The Health Resources and Services Administration and American
Society of Transplant Surgeons had no direct involvement in the study.
Results
The characteristics of living donor candidates who were accepted and not accepted are
depicted in Table 1. The overall proportion accepted (accepted donor candidates divided by
all donor candidates) was 405 of 1011 (40%). There were no significant differences in the
age, sex, ethnicity or race of accepted donor candidates compared with those who were not
accepted. Accepted donors had significantly lower body weight (by 5 kg) and BMI (26 ± 4.2
versus 28 ± 4.8; both P < 0.0001) than candidates who were not accepted. Accepted donor
candidates were significantly more likely to be an offspring, sibling, or spouse of the
recipient (P < 0.0001). The most common donor candidate was an offspring of the recipient
(31% of all donor candidates; 34% of accepted donor candidates). For some recipients,
several potential donors were evaluated. The probability of donor acceptance was higher for
the first donor evaluated (41%) than for the second (35%) or subsequent (30%), but these
differences were not statistically significant (P = 0.16). The overall rate of donor acceptance
was significantly higher during the early experience (47% from 1998-2000) compared with
later experience (35% from 2001-2003; P = 0.0002).
Demographics of the 819 LDLT recipient candidates, by donor acceptance status, and 7358
waitlisted DDLT candidates not considered for LDLT from the 9 A2ALL centers are shown
in Table 2. Among the LDLT recipient candidates, those who had at least 1 donor accepted
for donation were younger, had a lower BMI, a lower prevalence of ascites, lower MELD
scores, and significantly shorter times from listing to first donor evaluation. The number of
donors evaluated for each recipient was similar between the LDLT candidates who did and
did not have a donor accepted.
Differences between LDLT candidates with or without a donor accepted were substantially
less than differences between all LDLT candidates and DDLT candidates (Table 2).
Compared with all DDLT candidates, LDLT candidates were significantly more likely to be
women and white, and to weigh less and have lower BMI. Potential LDLT recipients were
significantly more likely to have cirrhosis caused by hepatitis C virus, hepatocellular
carcinoma, other primary hepatic malignancies, and cholestatic disorders and less likely to
have fulminant hepatic failure. LDLT candidates were no less likely to have alcoholic liver
disease than DDLT candidates. After February 2002, potential LDLT recipients had similar
MELD scores at the time of first donor evaluation compared with those among DDLT
candidates at the time of listing (16.0 ± 6.7 versus 15.8 ± 8.3; P = 0.62). However, LDLT
candidates were significantly more likely to have had a history of variceal hemorrhage, or
treatment with a transjugular intrahepatic portosystemic shunt. LDLT candidates were
significantly less likely to have had a history of prior upper abdominal surgery or to have
been in an intensive care unit at the time of donor evaluation compared with DDLT
candidates at the time of listing.
Table 3 shows the disposition of donor candidate evaluations. Sixty percent of evaluated
donors were not accepted, a medical contraindication being the most common reason (n =
173). The most common recipient-related reason that donors were not accepted was
availability of a DDLT before LDLT donation. There were no significant differences in the
distributions of donor-related or recipient-related reasons for rejection of donor candidates in
2001 to 2003 compared with 1998 to 2000 (P = 0.48).
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Twelve accepted donor candidates were taken to the operating room with the intent of
donation, but the procedure was not completed (“aborted donation”). One additional
accepted donor underwent right hepatic lobectomy, but the graft was not transplanted into
the intended recipient. Nine of the “aborted donation” cases occurred later in the LDLT
experience between 2001 and 2003.
A logistic regression model was fitted to estimate the adjusted odds of donor acceptance
associated with putative predictive factors (Table 4). With regard to donor age, candidates
between 18 and 40 years were the most likely to be accepted. Accepted donors were less
likely to be overweight (BMI, 25.0-29.9 kg/m2) or obese (BMI ≥30.0 kg/m2) and were more
likely to be family members (biological or spousal relationship). Potential donors evaluated
earlier in a center’s LDLT experience were twice as likely to be accepted for donation (P <
0.0001). Younger potential recipients and those with lower MELD scores were significantly
more likely to have their donor candidates accepted. Donor candidates were also more likely
to be accepted if the recipient had been listed for DDLT less than 23 days before first donor
evaluation. The medical center of evaluation was also a significant predictor of acceptance,
with a 10-fold range of odds ratios (OR 0.26 to 2.4 versus the average donor acceptance
over the A2ALL centers, P < 0.0001).
The overall c-statistic (area under the receiver operating characteristic curve) for the model
predicting donor acceptance was 0.731. The strongest predictors of donor acceptance
included (in descending order): medical center of evaluation (Δc-statistic = 0.060), donor
BMI (Δc-statistic = 0.022), year of donor evaluation (Δc-statistic = 0.012), recipient MELD
score (Δc-statistic = 0.010), time from recipient listing to first donor evaluation (Δc-statistic
= 0.009), recipient age (Δc-statistic = 0.006), donor–recipient relatedness (Δc-statistic =
0.005), and donor age (Δc-statistic = 0.003).
Discussion
This analysis provides perhaps the largest collective experience documenting the outcomes
of donor evaluation for LDLT among adults. Several of the results deserve comment.
Although it was anticipated that donor acceptance might have increased with greater
experience in donor evaluations, in fact the donor acceptance rate declined with greater
center experience. There are several likely explanations for the decreased rate of acceptance
over time. First, when LDLT was initially offered at each center, hundreds of patients were
already listed for deceased donor transplantation, some of whom were ideal candidates for
LDLT. Early in the experience of LDLT, a proportionally higher number of the recipients
with ideal donors may have been identified and were likely accepted for LDLT at a higher
rate. Once these ideal recipient-donor pairs were transplanted, the remaining donor
candidates were rejected at a higher rate during the evaluation. Second, transplant centers
may have become more conservative in their approach toward LDLT after the highly
publicized death of a living donor in 2001 in the United States. After this catastrophic event,
some centers may have become more conservative in their selection of donors in an attempt
to minimize the risk of unfavorable donor outcomes. The overall reduction in the number of
LDLT in the United States after 2001 by approximately 50% may reflect a more restrained
approach toward the procedure.11 Third, the institution of the MELD score as the basis for
deceased donor liver allocation may have impacted LDLT. After February 2002, when
MELD was introduced, fewer patients died on the waiting list, likely because of expedited
DDLT. Between 2001 and 2003, we noted a higher proportion of LDLT candidates who had
DDLT during the course of the donor’s evaluation.
As expected, donor candidates with higher BMI were much less likely to be accepted as
donors. Overweight and obese patients are higher-risk living liver donors because of greater
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likelihood of hepatic steatosis and medical problems (diabetes, hypertension, and heart
disease), which could increase the postoperative complications.12,13 However, recent data
have shown that selected obese candidates may successfully undergo donation without
evidence of increased complications.14 Accepted donor candidates were more likely to be
related to the recipient (including spouses) than rejected candidates. The most obvious
explanation is that the related candidates may have demonstrated a greater interest and
understanding of the donation procedure and therefore presented themselves as better
candidates.
Changes in the recipient’s condition were an important determinant of whether donor
candidates were accepted for operation. Thirteen percent of donor candidates were not
accepted because of a change in the recipient’s condition, the most common of which was
receipt of a DDLT. In these cases, the DDLT occurred before completion of the donor
evaluation. Acceptance as a living donor did not ensure that the patient would undergo the
operation. Thirteen approved donor candidates were taken to the operating room, but a
donor hepatectomy was not completed because of intraoperative recipient death or
unexpected findings in the donor or recipient. Each of these cases represents a failure of the
donor or recipient evaluation process.
The logistic regression analysis identified important predictors of donor acceptance.
Interestingly, several of the strongest predictors of donor acceptance were not related to any
specific donor factors: medical center of evaluation, year of evaluation, recipient age, and
recipient MELD. Perhaps younger, less sick recipient candidates evaluated early in the
experience at specific centers had more favorable donor candidates. Alternatively, donor
candidates may not have been evaluated independently of the recipient characteristics. That
is, donor candidates may have been viewed more favorably if their recipient was deemed a
better candidate. This issue requires further evaluation. Accepted donors were primarily the
first donors evaluated for a given recipient because of the fact that these donors made up the
majority of the subject population. However, the percentage of first donors accepted was
only slightly higher than that of second and subsequent donors.
We were somewhat surprised at the large variation in the likelihood of donor acceptance
based on the center of evaluation, and the explanation for this finding is not entirely clear.
These variations in acceptance rates may be attributable to subtle and unmeasured
differences in how transplant centers evaluate donors. That is, there may be important
differences in how donor candidates were prescreened before the formal donor evaluation,
which was the entry point for the A2ALL study. In addition, some of the difference may
have been attributable to the small number of donor evaluations performed at some of the
centers.
LDLT candidates differed substantially from DDLT candidates by demographic factors,
disease cause, and severity of illness. This difference was much greater than differences
between LDLT candidates with or without successful donor evaluation. This is not
surprising, given the effect of recipient characteristics on the likelihood of a potential LDLT
donor being accepted. Importantly, the differences between DDLT and LDLT candidates
point to potential problems in comparisons of transplant outcomes between groups of
patients who may differ in fundamental ways.
There are several notable weaknesses of our analysis. Most important, the retrospective
nature of this study precluded complete collection of data on all candidates. This was most
apparent in the proportion with missing demographic data among donor candidates who
were not accepted. Because the study was conducted up to 5 years after their evaluation,
many of the donor candidates were no longer in contact with the transplant center.
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Therefore, there was no opportunity to obtain missing data values in these candidates. In
contrast, the accepted living donor candidates, almost all of whom proceeded to donor
hepatectomy, often had ongoing relationships with the transplant center, which facilitated
data collection. Identification of the precise reason for rejecting donor candidates may have
been imperfect when determined in retrospect. For example, a donor may have had
extensive hepatic steatosis identified retrospectively as the indication for nonacceptance, but
elected not to donate independently of the biopsy findings. Another significant weakness of
this study is that we may not have captured the complexities of the donor evaluation process.
Our analysis allowed the selection of only 1 of a limited number of reasons for donor
nonacceptance when in some cases the reasons may have been multifactorial. For example, a
donor candidate may have had a large hepatic hemangioma and abnormal electrocardiogram
(either of which would preclude donation), but only a single reason was recorded for this
study. Finally, although the evaluation process at each center is similar, there are likely
subtle differences in the identification and selection of donors and recipients that could lead
to differences in outcomes of the donation process. Because of the nature of our analysis we
were not able to capture the effect of these differences on donor candidate outcomes.
One of the weaknesses of this study is that there are likely important differences in the
subtle details in each center’s approach to LDLT. Specifically, some centers may have been
more or less aggressive in recruiting patients for the procedure. In addition, the specific
approach to the donor evaluation, type of cross-sectional imaging used in assessment of
donor anatomy, and use of the liver biopsy in donor evaluation likely varied slightly
between the centers. We acknowledge that these subtle differences may not have been
accounted for in our analysis and could result in slight differences in the donor acceptance
rate between the 9 participating centers.
In summary, we have described the outcomes in a large group of donor candidates for
LDLT. We found that (1) the overall rate of acceptance for donor candidates was 40%; (2)
the acceptance rate has dropped over time; and (3) the strongest predictors of donor
acceptance, in decreasing order of importance, were center of evaluation, donor BMI, year
of evaluation, recipient MELD score, days from listing to first donor evaluation, recipient
age, donor–recipient relatedness, and donor age. These findings may aid the donor
evaluation process and allow an objective assessment of the likelihood of donor candidate
acceptance.
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Table 1
Characteristics of A2ALL Potential Donors (Evaluation Years 1998-2003)
Overall (n = 1,011) Donors Who WereAccepted (n = 405)
Donors Who Were Not
Accepted (n = 606)
Characteristic Mean (SD; range) or N (%) Mean (SD; range) or N (%) Mean (SD; range) or N (%) P Value
Age 37 (10.1; 18-59) 37 (9.6; 18-59) 38 (10.3; 18-59) 0.0846
Age (categories) 0.1676
 Age 18-39 577 (57%) 244 (60%) 333 (55%)
 Age 40-49 301 (30%) 116 (29%) 185 (31%)
 Age ≥ 50 130 (13%) 44 (11%) 86 (14%)
Sex 0.3430
 Female 446 (44%) 186 (46%) 260 (43%)
 Male 565 (56%) 219 (54%) 346 (57%)
Ethnicity * 0.7923
 Hispanic/Latino 171 (17%) 68 (17%) 103 (18%)
 Non-Hispanic/Non-Latino 820 (83%) 335 (83%) 485 (82%)
Race * 0.1129
 White 894 (90%) 366 (91%) 528 (89%)
 African-American 53 (5%) 15 (4%) 38 (6%)
 Other 46 (5%) 22 (5%) 24 (4%)
Height (cm) 173 (10.1; 145-211) 173 (10.0; 150-203) 173 (10.1; 145-211) 0.9234
Weight (kg) 81 (16.7; 41-146) 78 (15.3; 43-146) 83 (17.4; 41-146) <0.0001
Body mass index (kg/m2) 27 (4.6; 16-57) 26 (4.2; 17-57) 28 (4.8; 16-50) <0.0001
Body mass index (categories) <0.0001
 BMI < 18.5 11 (1%) 6 (1%) 5 (1%)
 BMI 18.5-24.9 296 (29%) 148 (37%) 148 (24%)
 BMI 25.0-29.9 408 (40%) 182 (45%) 226 (37%)
 BMI ≥ 30 208 (21%) 61 (15%) 147 (24%)
 Missing 88 (9%) 8 (2%) 80 (13%)
Relatedness to recipient <0.0001
 Biologically related
  Parent 27 (3%) 9 (2%) 18 (3%)
  Offspring 317 (31%) 139 (34%) 178 (29%)
  Sibling 210 (21%) 92 (23%) 118 (19%)
  Other biological 95 (9%) 35 (9%) 60 (10%)
 Not biologically related
  Spouse 86 (9%) 51 (13%) 35 (6%)
  Other nonbiological 223 (22%) 78 (19%) 145 (24%)
 Unknown/Missing 53 (5%) 1 (<1%) 52 (9%)
Order of donor evaluated for
    their recipient candidate *
0.1589
 1st donor evaluated 819 (81%) 339 (84%) 480 (79%)
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Overall (n = 1,011) Donors Who WereAccepted (n = 405)
Donors Who Were Not
Accepted (n = 606)
Characteristic Mean (SD; range) or N (%) Mean (SD; range) or N (%) Mean (SD; range) or N (%) P Value
 2nd donor evaluated 147 (15%) 52 (13%) 95 (16%)
 3rd-7th donor evaluated 43 (4%) 13 (3%) 30 (5%)
*
Missing at most 2%.
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Table 2
Characteristics of A2ALL Potential LDLT Recipients by Donor Acceptance Status Compared With DDLT




at Least One Donor



















Age 49.0 (10.9) 51.1 (9.7) 0.0033 50.7 (10.3) 0.0635
Age (categories) 0.0290 0.2271
 Age 18-29 7% 4% 4%
 Age 30-49 42% 37% 41%
 Age ≥ 50 51% 59% 54%
Sex 0.4905 0.0230
 Female 41% 44% 39%
 Male 59% 56% 61%
Ethnicity * 0.6390 0.0708
 Hispanic/Latino 20% 19% 17%
 Non-Hispanic/Non-Latino 80% 81% 83%
Race * 0.0834 0.0005
 White 90% 89% 84%
 African-American 3% 7% 7%
 Asian 4% 2% 6%
 Other 3% 2% 3%
Height (cm) 171.3 (10.8) 170.9 (9.8) 0.6143 171.0 (11.0) 0.7865
Weight (kg) 78.5 (18.2) 80.4 (17.8) 0.1296 82.7 (20.4) <0.0001
Body mass index (kg/m2) 26.7 (5.3) 27.4 (5.2) 0.0526 28.5 (11.6) 0.0005
Body mass index (categories) 0.0898 <0.0001
 BMI < 18.5 3% 2% 2%
 BMI 18.5-24.9 38% 35% 28%
 BMI 25.0-29.9 38% 34% 31%
 BMI ≥ 30 20% 28% 29%
 Missing 1% 1% 11%
Education level * 0.2362 0.0003
 None <1% 0% 1%
 Grade/High School (0-12) 35% 41% 44%
 Tech/Bachelor/Graduate 49% 45% 40%
 Unknown 16% 14% 14%
Diagnosis at enrollment and listing (more
than
 one diagnosis per patient possible)
 HCV 47% 46% 0.7831 42% 0.0073
 HCC 14% 11% 0.2040 5% <0.0001
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 Alcohol 13% 15% 0.3862 16% 0.2699
 Cholestatic liver disease 18% 19% 0.7275 10% <0.0001
 Noncholestatic cirrhosis other than HCV/
alcohol 21% 20% 0.8327 21% 0.5761
 Metabolic disease 3% 3% 0.7556 2% 0.0995
 Biliary atresia 1% 0% 0.0765 <1% 0.2941
 Malignancy other than HCC 3% 2% 0.3174 <1% <0.0001
 Fulminant 2% 1% 0.1124 6% <0.0001
 Other 3% 4% 0.4903 6% <0.0017
Ascites * 61% 68% 0.0297 65% 0.4920
Variceal bleed * 17% 19% 0.5211 5% <0.0001
Upper abdominal surgery * 19% 20% 0.9234 27% <0.0001
Spontaneous bacterial peritonitis * 8% 5% 0.1509 6% 0.4725
Transjugular intrahepatic portosystemic
shunt *
9% 12% 0.0711 5% <0.0001
MELD 0.0388
 Pre-MELD period 15.5 (7.1) 16.0 (7.2) N/A N/A
 Post-MELD period 14.5 (5.4) 17.1 (7.2) 15.8 (8.3) 0.6249
MELD categories § 0.0558
 6-10 25% 20% 26%
 11-20 58% 56% 54%
 21-30 13% 18% 10%
 31-40 4% 6% 9%
Recipient medical condition * 0.9274 0.0094
 ICU 4% 3% 5%
 Hospitalization, no ICU 7% 8% 6%
 Not hospitalized 89% 89% 89%
Mechanical ventilation * 2% 2% 0.7359 3% 0.2044
Renal failure requiring dialysis * 4% 3% 0.7744 2% 0.0581
Diabetes mellitus * 19% 21% 0.4247 19% 0.5736
Angina/coronary artery disease * 3% 5% 0.2503 2% 0.0192
Drug treated systemic hypertension * 12% 13% 0.7686 13% 0.8236
Days from listing to first donor evaluation 194.9 (303.3) 258.5 (352.3) 0.0059 N/A N/A
Number of evaluated donors per recipient
* 0.5662 N/A
 1 83% 81% N/A
 2 14% 15% N/A
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 3-7 3% 4% N/A
*
Missing at most 3%.
†
Recipients with at least 1 donor accepted versus recipients with no accepted donor.
‡
All potential LDLT recipients versus DDLT waitlist candidates not considered for LDLT.
§
No significant difference found between MELD scores from the pre-MELD and post-MELD periods in A2ALL Potential LDLT Recipients (P =
0.60). Therefore, the MELD categories exhibited above incorporate MELD scores from both periods.
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Table 3
Disposition of A2ALL Potential Donors (n = 1011)
Characteristic n (%)
Potential Donors Who Were Not Accepted 606 (60%)
  Donor-related reasons
  Medical contraindictions 173 (17%)
  Anatomical contraindications 115 (11%)
  Donor liver steatosis 65 (6%)
  Declined to donate 68 (7%)
  Psychosocial contraindications 55 (5%)
  Recipient-related reasons
  Recipient received DDLT 65 (6%)
  Recipient died 24 (2%)
  Recipient too sick/removed from transplant consideration 19 (2%)
  Recipient improved 8 (1%)
  Recipient declined/refused organ 5 (<1%)
  Other/unknown 9 (1%)
Potential donors who were accepted 405 (40%)
  Successful donation 392 (39%)
  Went to operating room but procedure aborted 12 (1%)
  Graft resected but not transplanted 1 (<1%)
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Table 4
Logistic Regression Model of Donor Acceptance
Variable* Adjusted Odds Ratio 95% Confidence Limits P Value
Donor age
 18 ≤ donor age <40 1.00 Reference
 40 ≤ donor age <50 0.81 0.57 1.14 0.2256
 50 ≤ donor age <60 0.61 0.38 0.96 0.0332
Donor BMI
 BMI ≤ 24.9 1.00 Reference
 25.0 ≤ BMI ≤ 29.9 0.77 0.55 1.06 0.1118
 BMI ≥ 30 0.31 0.20 0.47 <0.0001
Relatedness to recipient
 Biologically related/Spouse 1.51 1.05 2.16 0.0258
 Nonbiological (excluding spouse) 1.00 Reference
Era of donor evaluation
 1998-2000 2.03 1.48 2.79 <0.0001
 2001-2003 1.00 Reference
Recipient age
 18 ≤ recipient age < 30 2.08 1.17 3.72 0.0132
 30 ≤ recipient age < 50 1.37 1.01 1.87 0.0446
 50 ≤ recipient age < 76 1.00 Reference
Recipient MELD
 6 ≤ MELD ≤ 10 1.85 1.17 2.93 0.0081
 11 ≤ MELD ≤ 20 1.77 1.18 2.67 0.0063
 21 ≤ MELD ≤ 40 1.00 Reference
Days from recipient listing to first donor evaluation
 < 23 Days 1.66 1.16 2.36 0.0052
 ≥ 23 Days 1.00 Reference
A2ALL center
 Range of ORs among 9 centers 0.26-2.44 <0.0001
 Average over all A2ALL centers 1.00 Reference
*
Variables tested and excluded from the model included: donor gender, donor ethnicity, donor race, donor alkaline phosphatase, donor bilirubin,
donor case number, number of evaluated donors per recipient, order of donors evaluated per recipient, recipient gender, recipient ethnicity,
recipient race, recipient diagnosis, recipient BMI, donor-recipient ethnicity match, and estimated graft weight-recipient weight ratio.
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